Company / Book Value per Share
Nurix Therapeutics, Inc. Book Value per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$7.101
FY2025
5-year range
$4.25 / $10.817
FY2021-FY2025
Trend
-34.4%
vs FY2024
Sector context
#83 of 209
Health Care
What the data says
At $7.101, Nurix Therapeutics, Inc.'s book value per share ranks #83 of 209 in the Health Care sector. Book Value per Share has fluctuated over the past 7 years, ranging from -$17.529 in FY2019 to $80.735 in FY2020.
Based on SEC 10-K filings.
$7.101 in FY2025 with a 5-year CAGR of -38.5%.
Improved from $4.25 to $7.101 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- -38.5%
- 10-Year CAGR
- -
Sector benchmark
#83 of 209 in Health CareTop 40% of 209This company $7.101 Sector average $215.686
▼
-96.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -38.5%, indicating a declining trend.
- In FY2025, book value per share decreased 34.4% year-over-year.
- Ranks #83 out of 209 companies in the Health Care sector.
- Peak book value per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.101 | -34.4% |
| FY2024 | $10.817 | +154.5% |
| FY2023 | $4.25 | -44.5% |
| FY2022 | $7.664 | +2.6% |
| FY2021 | $7.469 | -90.7% |
| FY2020 | $80.735 | +560.6% |
| FY2019 | -$17.529 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026